Results for Endocrinology Disorders

1 - 10 of 55

Dr. Morrow’s research involves quality improvement related to program development in oncology, eating disorders, and endocrinology, as well as understanding factors that contribute to mental health inequities.

E-mail:

morrowl1 [at] chop.edu

Charles A. Stanley, MD

Dr. Stanley’s lab has identified many of the genes and syndromes associated with congenital hyperinsulinism including ABCC8, GCK, GLUD1, and Turner and Beckwith syndromes. Working with clinical and rodent model studies, his lab team has identified distinctive phenotypes of these disorders, including diazoxide unresponsiveness, leucine sensitivity, and protein sensitivity. Dr. Stanley continues to seek new diagnostic and treatment paradigms for infants with acquired and genetic disorders of hyperinsulinism.

E-mail:

stanleyc [at] chop.edu

David R. Weber, MD, MSCE

Dr. Weber is a clinical researcher focused on improving bone health in children. He is currently focused on investigating the effects of effects of type 1 diabetes and Duchenne muscular dystrophy on the skeleton.

E-mail:

weberd [at] chop.edu

Michael A. Levine, MD, FAAP, FACP, MACE

Dr. Levine has an active laboratory research program that complements and extends his clinical studies. He has identified the molecular basis of several inherited disorders of mineral metabolism. His research interests extend to the molecular basis for embryological development of the parathyroid glands.

E-mail:

levinem [at] chop.edu

Sogol Mostoufi-Moab, MD, MSCE

Dr. Mostoufi-Moab's clinical and research program is focused on endocrine late effects after childhood cancer therapy. She has unique dual training in pediatric endocrinology and oncology with a master's degree in clinical epidemiology. The goal of her research program is to pursue a mechanistic understanding of metabolic and endocrine disorders that occur due to cancer therapy.

E-mail:

moab [at] chop.edu

Adda Grimberg, MD

Dr. Grimberg investigates the growth hormone (GH)/insulin-like growth factor (IGF)-I axis and clinical issues related to child growth. Her recent research is focused on disparities in, and the decision-making related to, the medical management of children with short stature. She is fascinated by how differential societal pressures for tallness and the advent of an expensive therapeutic have transformed a fundamental aspect of pediatric healthcare.

E-mail:

grimberg [at] chop.edu

Katherine Lord, MD

Dr. Lord's research focuses on congenital hyperinsulinism, a rare disorder resulting in severe hypoglycemia at birth.

E-mail:

lordk [at] chop.edu

Jacquelyn Anne Hatch-Stein, MD

Dr. Hatch-Stein's research interests include diabetes, thyroid disorders, and disorders of growth and puberty. Recent clinical research projects include "Bone Health and Cardiovascular Risk in Turner Syndrome" and "Patterns of Height Velocity in Down Syndrome."

E-mail:

hatchsteinj [at] chop.edu

Maria G. Vogiatzi, MD

Dr. Vogiatzi's research goals are to improve the health of children with gonadal disorders and understand the role of glucocorticoids, androgens, and sex steroids in health and disease.

E-mail:

vogiatzim [at] chop.edu

Thomas F. Kolon, MD

Dr. Kolon is an expert in the care of children with genital disorders and renal/bladder/prostate cancers. His expertise in pediatric urologic oncology includes optimizing organ-sparing surgery and preservation of fertility in oncology patients.

E-mail:

kolon [at] chop.edu